Features Australia

Don’t axe QoVax

A priceless biobank with the answers to long Covid is threatened with destruction

18 March 2023

9:00 AM

18 March 2023

9:00 AM

Why has the Queensland health department withdrawn funding for its award-winning QoVax research program studying the safety and efficacy of Covid-19 vaccines?

Only last August, Queensland’s Health Minister, Yvette D’Ath, and the chief operating officer of Queensland Health, Dr David Rosengren, celebrated the work of the QoVax team, led by Professor Janet Davies, which was a highly commended finalist in the Pursuing Innovation category at the 2022 Queensland Health Awards for Excellence.

Already a subscriber? Log in

Get 10 issues
for $20

Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $20.

  • Delivery of the weekly magazine
  • Unlimited access to spectator.com.au and app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER

You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.


Comments

Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Close